It has been a major issue for sure.
The interesting thing is that a lot of these medications are generics and have been generics for decades. About 77% of the medications that do go short are generics, so we should be able to make them relatively easily. It's just a matter of money.
The reason I brought up the sedatives, in particular, is that I've heard from many intensivists in the hospitals down south that they've had to do rotations, so they conserve supplies and have to switch to another formulation. None of this is ideal.
The terrible thing when it comes to fentanyl and other opiates, for example—we did have morphine shortages—is that those are used in palliative care as well, so there is a lot of concern. We were liaising with the palliative care associations on that since, obviously, that can cause undue suffering for people at the ends of their lives.